Abstract:Inflammasomes are multiprotein complexes that drive inflammation and contribute to protective immunity against pathogens and immune pathology in autoinflammatory diseases. Inflammasomes assemble when an inflammasome scaffold protein senses an activating signal and forms a signaling platform with the inflammasome adaptor protein ASC. The NLRP subfamily of NOD-like receptors (NLRs) includes inflammasome nucleators (such as NLRP3) and also NLRP12, which is genetically linked to familial autoinflammatory disorders that resemble diseases caused by gain-of-function NLRP3 mutants that generate a hyperactive NLRP3 inflammasome. We performed a screen to identify ASC inflammasome–nucleating proteins among NLRs that have the canonical pyrin-NACHT-LRR domain structure. Only NLRP3 and NLRP6 could initiate ASC polymerization to form "specks," and NLRP12 failed to nucleate ASC polymerization. However, wild-type NLRP12 inhibited ASC inflammasome assembly induced by wild-type and gain-of-function mutant NLRP3, an effect not seen with disease-associated NLRP12 mutants. The capacity of NLRP12 to suppress NLRP3 inflammasome assembly was limited to human NLRP3 and was not observed for wild-type murine NLRP3. Furthermore, peripheral blood mononuclear cells from patients with an NLRP12 mutant–associated inflammatory disorder produced increased amounts of the inflammatory cytokine IL-1β in response to NLRP3 stimulation. Thus, our findings provide insights into NLRP12 biology and suggest that NLRP3 inhibitors in clinical trials for NLRP3-driven diseases may also be effective in treating NLRP12-associated autoinflammatory diseases.

Caspase-11 interaction with NLRP3 potentiates the noncanonical activation of the NLRP3 inflammasome

Caspase-6 Promotes Activation of the Caspase-11-nlrp3 Inflammasome During Gram-Negative Bacterial Infections.

Activation of the NLRP1B inflammasome by caspase-8

Non-canonical inflammasome activation targets caspase-11

Catalytic activity and autoprocessing of murine caspase-11 mediate noncanonical inflammasome assembly in response to cytosolic LPS

Initiation and perpetuation of NLRP3 inflammasome activation and assembly

NLRP3 cages revealed by full-length mouse NLRP3 structure control pathway activation

An endogenous caspase-11 ligand elicits interleukin-1 release from living dendritic cells

Structural Mechanisms of NLRP3 Inflammasome Assembly and Activation

How location and cellular signaling combine to activate the NLRP3 inflammasome

Apoptosis-Associated Speck-like Protein Containing a CARD Forms Specks but Does Not Activate Caspase-1 in the Absence of NLRP3 during Macrophage Swelling

NLRP12 interacts with NLRP3 to block the activation of the human NLRP3 inflammasome

Sensing damage by the NLRP3 inflammasome

Cathepsin B Is Required for NLRP3 Inflammasome Activation in Macrophages, Through NLRP3 Interaction

Activation and Regulation of NLRP3 by Sterile and Infectious Insults

Crystal structure of caspase-11 CARD provides insights into caspase-11 activation

NLRP3 Phosphorylation is an Essential Priming Event for Inflammasome Activation.

Inflammatory caspases are innate immune receptors for intracellular LPS

The NLRP3 inflammasome: activation and regulation

The NLRP3 inflammasome: molecular activation and regulation to therapeutics

The orphan receptor Nur77 binds cytoplasmic LPS to activate the non-canonical NLRP3 inflammasome